Research Supported

Doxy-PEP. Post-exposure prophylaxis for bacterial STIs.

The DoxyPEP trial (Luetkemeyer et al., NEJM 2023) demonstrated that 200mg doxycycline taken within 72 hours of condomless sex reduced the combined incidence of chlamydia, syphilis, and gonorrhea by approximately two-thirds among MSM and transgender women — including roughly 88% lower chlamydia, 87% lower syphilis, and 55% lower gonorrhea per-pathogen.

Doxy-PEP fills a gap in sexual health. Condoms prevent everything but are not always used. PrEP protects against HIV but not bacterial STIs. Doxy-PEP is designed to prevent chlamydia, syphilis, and gonorrhea on an as-needed basis, taken after potential bacterial exposure.

For patients who want a research-backed option for post-exposure bacterial STI prevention, doxycycline offers a single 200mg dose taken within 72 hours (ideally within 24 hours).

Prescription required · Free shipping
vial

Doxycycline

A targeted clinical strategy for proactive bacterial wellness and protection.
Starting at
$90.00
100% Online
Board-Certified
Fast Shipping

Clinical Trial Evidence

Doxy-PEP by the numbers: data from the DoxyPEP trial.

Phase III trial results in MSM and transgender women. These are the figures that drive post-exposure prophylaxis protocols.

~⅔
Combined STI rate reductionDoxyPEP lowered combined chlamydia, syphilis, and gonorrhea incidence by approximately two-thirds vs. standard care (Luetkemeyer et al., NEJM 2023)
72 hrs
Maximum dosing windowDoxycycline must be taken within 72 hours of condomless sex for effectiveness
200 mg
Single dose per exposureOne 200mg dose is taken after potential bacterial exposure, not daily
24 hrs
Optimal dosing windowMaximum efficacy is achieved when taken within 24 hours; effectiveness declines after that window
DoxyPEP trial resultsLuetkemeyer et al., New England Journal of Medicine (2023) — Open-label randomized trial in MSM and transgender women; combined STI incidence lowered by ~two-thirds vs. standard care. Per-pathogen relative risk reductions in the PrEP cohort: chlamydia ~88% (RR 0.12), syphilis ~87% (RR 0.13), gonorrhea ~55% (RR 0.45). | Off-label use — Doxycycline is an FDA-approved tetracycline antibiotic; Doxy-PEP protocol represents off-label use for post-exposure bacterial STI prophylaxis
Individual results vary. Efficacy data is from a controlled Phase III trial in specific populations (MSM, transgender women). Effectiveness in other populations and behavioral contexts may differ. Results are not guaranteed. Doxy-PEP is not recommended for daily prophylactic use due to antibiotic resistance concerns.

How Doxycycline Works

The bacterial targets. The window. The mechanism.

Doxycycline is a tetracycline-class antibiotic that halts bacterial protein synthesis before infection establishes. It targets three of the most common bacterial STIs via a single mechanism.

Protein Synthesis Block

Doxycycline binds to the bacterial 30S ribosomal subunit, halting protein synthesis and preventing bacterial replication. This stops infection establishment before it becomes systemic.

Broad-Spectrum Coverage

One dose covers three major bacterial STIs: Chlamydia trachomatis, Treponema pallidum (syphilis), and Neisseria gonorrhoeae (gonorrhea). No separate medications needed.

Post-Exposure Window

Doxy-PEP is reactive prophylaxis, not daily prevention. Unlike PrEP (daily HIV prevention), you take a single 200mg dose after potential exposure, within 72 hours.

How to Use Doxy-PEP

The post-exposure protocol: four sequential steps.

Doxy-PEP is taken as a single dose after potential condomless sexual exposure. Timing is critical; earlier is better.

Potential Exposure

Condomless sex occurs, or a condom breaks. The window for Doxy-PEP begins now.

Take 200mg Dose

Take a single 200mg doxycycline tablet as soon as possible; ideally within 24 hours, no later than 72 hours.

Take with Food

Take with food and a full glass of water to minimize gastrointestinal upset and improve absorption.

Continue Testing

Schedule STI testing at baseline, 2 weeks, and 3 months. Doxy-PEP does not replace regular screening.

Prevention Options

Condoms, PrEP, and Doxy-PEP: how they fit together.

Each tool prevents different pathogens. Doxy-PEP fills the gap for bacterial STIs when condoms are not used.

Condoms

Physical barrier

CoverageAll STIs (if used consistently)
When usedEvery sexual encounter
Requires prescriptionNo
CostMinimal

PrEP

Daily prevention

CoverageHIV only
When usedDaily, ongoing
Requires prescriptionYes
CostVariable by formulation

Critical Windows

Timing matters. These are the windows that determine outcome.

Optimal Window

Within 24 Hours

Maximum efficacy is achieved when doxycycline is taken within 24 hours of exposure. Do not delay; sooner is better.

Maximum Window

Within 72 Hours

The absolute outer window is 72 hours. Efficacy declines significantly after 24 hours. After 72 hours, post-exposure prophylaxis is not recommended.

Follow-up Schedule

Every 3 Months

Schedule routine STI testing every 3 months regardless of Doxy-PEP use. Post-exposure prophylaxis does not replace regular screening.

Safety considerations and side effects.

Doxycycline is well-tolerated for single-dose post-exposure prophylaxis. Be aware of potential interactions and photosensitivity.

Common Side Effects

The most frequent effects are gastrointestinal upset (nausea, abdominal discomfort), especially on an empty stomach. Photosensitivity is possible; use broad-spectrum sunscreen. Most side effects resolve quickly after a single dose.

Drug Interactions

Do not take doxycycline within 2 hours of dairy products, antacids, or iron supplements, as these reduce absorption. Inform your provider of all current medications. Some interactions are possible with anticoagulants.

When to Contact Us

Reach out if you experience persistent nausea, severe photosensitivity reaction, signs of yeast infection, or have questions about dosing. Your provider is here to monitor your response.

Off-label use and antibiotic resistance.

Doxy-PEP is an off-label use of doxycycline. The drug itself is FDA-approved as an antibiotic; the post-exposure prophylaxis protocol is based on clinical trial evidence but represents off-label prescribing. Doxy-PEP is designed for intermittent post-exposure use only, not daily prophylaxis. Overuse contributes to antibiotic resistance. Do not use daily; take only after potential exposure.

Frequently asked question

No. Doxy-PEP only covers bacterial STIs: chlamydia, syphilis, and gonorrhea. It does not protect against HIV, herpes, HPV, or any viral pathogen. If you are at risk for HIV or want HIV prevention, discuss PrEP with your Obsidian Genetics provider. PrEP and Doxy-PEP can be used together; they protect against different pathogens.

Doxy-PEP is designed for intermittent post-exposure use, not daily prophylaxis. Frequent or daily use increases the risk of antibiotic resistance and side effects. It is intended to be taken only after condomless sex or condom failure, within 72 hours. If you are having frequent exposures, discuss more consistent prevention strategies (consistent condom use or PrEP) with your provider.

No. Doxycycline is an antibiotic and only works against bacteria. It is ineffective against viral STIs, including herpes (HSV), HPV, and cytomegalovirus. For herpes prevention or suppression, your provider may recommend antivirals like valacyclovir. For HPV, discuss vaccination status and strategies with your care team.

Yes. Regular STI testing is essential. Doxy-PEP reduces risk but does not guarantee prevention. Test at baseline, 2 weeks post-exposure, and then every 3 months. Some infections (particularly syphilis) may take time to become detectable. Your Obsidian Genetics provider will recommend a testing schedule based on your risk profile.

Yes. Take doxycycline with food and a full glass of water. This reduces nausea and gastrointestinal upset. Avoid taking it with dairy, antacids, or iron supplements within 2 hours before or after dosing, as these reduce absorption. Your prescription will include detailed instructions on how to take your dose.

Off-Label Medication Notice: Doxycycline (Doxy-PEP) is prescribed for post-exposure prophylaxis of bacterial STIs. This represents off-label use of an FDA-approved antibiotic. Doxycycline itself is FDA-approved as an antibiotic for various infections; the Doxy-PEP post-exposure prophylaxis protocol is evidence-based but off-label. It is prescribed by a licensed provider for individual patient use. Doxy-PEP is not recommended for daily prophylactic use due to antibiotic resistance concerns.

Efficacy & Testing: Clinical trial data (Luetkemeyer et al., NEJM 2023) showed approximately two-thirds reduction in combined bacterial STI incidence, with per-pathogen relative risk reductions of approximately 88% for chlamydia, 87% for syphilis, and 55% for gonorrhea in MSM and transgender women. Efficacy varies by individual, population, and behavioral factors. Results are not guaranteed. Doxy-PEP is not a replacement for regular STI testing, consistent condom use, or other prevention strategies. Test at baseline, 2 weeks, and every 3 months regardless of Doxy-PEP use.

Not Medical Advice: The content on this page is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Consult a qualified healthcare provider before starting any new treatment. All Obsidian Genetics prescriptions are issued by licensed providers following a clinical review.

Bacterial Coverage Only: Doxy-PEP does not protect against viral STIs, including HIV, herpes (HSV), and HPV. It covers only bacterial pathogens: Chlamydia trachomatis, Treponema pallidum (syphilis), and Neisseria gonorrhoeae (gonorrhea). For HIV prevention, discuss PrEP or other strategies with your provider.

Citations & Evidence: DoxyPEP trial data: Luetkemeyer et al., New England Journal of Medicine (2023); Phase III randomized controlled trial demonstrating 65% reduction in chlamydia and syphilis, ~55% reduction in gonorrhea in MSM and transgender women. Doxycycline mechanism of action: tetracycline-class antibiotic; inhibits 30S ribosomal subunit protein synthesis.

Doxycycline is an FDA-approved drug in the tetracycline antibiotic class. Obsidian Genetics is a telehealth platform connecting patients with licensed providers. Prescription required. ©2024 Obsidian Genetics. All rights reserved.